Add to ORKGProlonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF
Targeting the cell cycle is an attractive anticancer strategy, as its dysregulation is a common, if ...
Cyclin-dependent kinases (CDKs) mediate cell cycle progression, regulating transition from G1 to S p...
Purpose: Loss of cell-cycle control is a hallmark of cancer, which can be targeted with agents, incl...
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotre...
(CDK4) and CDK6 by gain of function or loss of inhibition is common in human cancer, including multi...
vivo activity of combined PI3K/mTOR and MEK-inhibition in a KrasG12D;Pten deletion mouse model of ov...
The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therap...
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
AbstractThe cyclin D-cyclin dependent kinase (CDK) 4/6-inhibitor of CDK4 (INK4)-retinoblastoma (Rb) ...
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemothe...
Fulltext embargoed for: 12 months post date of publicationThe recent clinical success of targeted th...
Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through s...
Targeting the cell cycle is an attractive anticancer strategy, as its dysregulation is a common, if ...
Cyclin-dependent kinases (CDKs) mediate cell cycle progression, regulating transition from G1 to S p...
Purpose: Loss of cell-cycle control is a hallmark of cancer, which can be targeted with agents, incl...
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotre...
(CDK4) and CDK6 by gain of function or loss of inhibition is common in human cancer, including multi...
vivo activity of combined PI3K/mTOR and MEK-inhibition in a KrasG12D;Pten deletion mouse model of ov...
The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therap...
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
AbstractThe cyclin D-cyclin dependent kinase (CDK) 4/6-inhibitor of CDK4 (INK4)-retinoblastoma (Rb) ...
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
Cyclin-dependent kinases (CDKs) drive cell cycle progression and control transcriptional pro-cesses....
targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemothe...
Fulltext embargoed for: 12 months post date of publicationThe recent clinical success of targeted th...
Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through s...
Targeting the cell cycle is an attractive anticancer strategy, as its dysregulation is a common, if ...
Cyclin-dependent kinases (CDKs) mediate cell cycle progression, regulating transition from G1 to S p...
Purpose: Loss of cell-cycle control is a hallmark of cancer, which can be targeted with agents, incl...